WeLeader Biomedical Co., Ltd.
7713
Rank in Stocks
#19775
WeLeader Biomedical Co. Ltd. is primarily involved in the development and... WeLeader Biomedical Co. Ltd. is primarily involved in the development and distribution of medical diagnostic instruments and related supplies. The company offers specialized products such as integrated systems for serum biochemistry, alongside comprehensive solutions for clinical care and the management of medical information. Established on April 28, 2003, its principal operations are based in Kaohsiung City, Taiwan.
Share Price
$2.15
Last synced: 2026-11-09
Market Cap
$97.88M
Change (1 day)
1.13%
Change (1 year)
-10.22%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade WeLeader Biomedical Co., Ltd. (7713)
Category
Healthcare
EPS for WeLeader Biomedical Co., Ltd. (7713)
EPS as of June 2026 TTM: $0.17
According to WeLeader Biomedical Co., Ltd.'s latest financial reports, its current EPS (TTM) is $0.17. At the end of 2025 the company had an EPS of $0.15, an increase over its 2024 EPS of $0.12.
EPS history for WeLeader Biomedical Co., Ltd. from 2020 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.17 | 13.00% |
| 2025 | $0.15 | 18.62% |
| 2024 | $0.12 | 2.21% |
| 2023 | $0.12 | -15.05% |
| 2022 | $0.14 | 4.97% |
| 2021 | $0.14 | 225.48% |
| 2020 | $0.04 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $39.05 | 22,938.35% |
US
|
|
| $17.99 | 10,513.57% |
US
|
|
| $7.77 | 4,484.07% |
US
|
|
| $17.99 | 10,513.57% |
US
|
|
| $0.04 | -74.34% |
AU
|
Questions about WeLeader Biomedical Co., Ltd.'s earnings per share (EPS)
What is WeLeader Biomedical Co., Ltd.'s earnings per share (EPS)?
WeLeader Biomedical Co., Ltd.'s earnings per share (EPS) over the last twelve months is $0.17, as of Jun 2026.
What was WeLeader Biomedical Co., Ltd.'s earnings per share (EPS) in 2025?
In 2025, WeLeader Biomedical Co., Ltd.'s earnings per share (EPS) was $0.15, 25.00% more than in 2024 ($0.12).
How has WeLeader Biomedical Co., Ltd.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, WeLeader Biomedical Co., Ltd.'s earnings per share (EPS) went from $0.04 to $0.15, an average growth of 30.26% a year.
How does WeLeader Biomedical Co., Ltd.'s earnings per share (EPS) compare with similar companies?
WeLeader Biomedical Co., Ltd.'s earnings per share (EPS) ($0.17) is higher than that of 1 of the 5 similar companies listed above. The highest among them is McKesson Corporation, with $39.05.